Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Pescado Pharmaceuticals is an Egyptian pharmaceutical and nutraceutical company headquartered in Cairo, specializing in the development, manufacturing, and marketing of therapeutic solutions and health supplements. The company's portfolio addresses key therapeutic areas including cardiovascular health, gastroenterology, and metabolic disorders, with prominent products such as Timbestatin for cholesterol management and Esomium for acid-related conditions. Beyond prescription medications, Pescado offers a diverse range of specialized supplements, including probiotics, multivitamins, and amino acid formulations designed for geriatric and hepatic support. The company maintains an active pipeline of combination therapies and advanced formulations aimed at improving patient quality of life within the Egyptian and regional healthcare markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Pescado Pharmaceuticals.